Pfizer Inc. (NYSE:PFE) and Array BioPharma Inc. (NASDAQ: ARRY) announced that they have entered into a definitive merger agreement under which Pfizer will acquire Array. Pfizer has agreed to acquire Array for $48 per share in cash, for a total enterprise value of approximately $11.4 billion.
Morrow Sodali is serving as the information agent for this transaction.
Download the pdf to see the Wall Street Journal ad.
Related News
Sodali & Co’s Prashilta Naidu Featured in ICGN Future Leaders Committee on Board Effectiveness
12 December 2025
Activist Funds Top €3.34 Billion in Spain
07 December 2025
For-Profit: Treasury extends the entry into force in Verifactu
05 December 2025
Sodali & Co Celebrates Excellence in Financial PR
02 December 2025
Media enquiries
To contact our global experts for comments please get in touch below.
Contact us chevron_right